<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2017.7524</article-id>
<article-id pub-id-type="publisher-id">mmr-16-05-7205</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Shear stress induces human aortic endothelial cell apoptosis via interleukin-1 receptor-associated kinase 2-induced endoplasmic reticulum stress</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Pan</surname><given-names>Longfei</given-names></name>
<xref rid="af1-mmr-16-05-7205" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Hong</surname><given-names>Zhou</given-names></name>
<xref rid="af2-mmr-16-05-7205" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Yu</surname><given-names>Lei</given-names></name>
<xref rid="af3-mmr-16-05-7205" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Gao</surname><given-names>Yanxia</given-names></name>
<xref rid="af1-mmr-16-05-7205" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Rui</given-names></name>
<xref rid="af1-mmr-16-05-7205" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Feng</surname><given-names>Hui</given-names></name>
<xref rid="af1-mmr-16-05-7205" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Su</surname><given-names>Lijuan</given-names></name>
<xref rid="af1-mmr-16-05-7205" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Gang</given-names></name>
<xref rid="af1-mmr-16-05-7205" ref-type="aff">1</xref>
<xref rid="c1-mmr-16-05-7205" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-16-05-7205"><label>1</label>Department of Emergency Medicine, The Second Affiliated Hospital of Xi&#x0027;an Jiaotong University, Xi&#x0027;an, Shaanxi 710004, P.R. China</aff>
<aff id="af2-mmr-16-05-7205"><label>2</label>Department of Emergency Medicine, The Fifth Hospital of Xi&#x0027;an, Xi&#x0027;an, Shaanxi 710082, P.R. China</aff>
<aff id="af3-mmr-16-05-7205"><label>3</label>Department of Basic Medicine, Xi&#x0027;an Medical College, Xi&#x0027;an, Shaanxi 710068, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-16-05-7205"><italic>Correspondence to</italic>: Professor Gang Wang, Department of Emergency Medicine, The Second Affiliated Hospital of Xi&#x0027;an Jiaotong University, 157 Xiwu Road, Xi&#x0027;an, Shaanxi 710004, P.R. China, E-mail: <email>jgowhv@sina.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub"><month>05</month><year>2017</year></pub-date>
<pub-date pub-type="epub"><day>19</day><month>09</month><year>2017</year></pub-date>
<volume>16</volume>
<issue>5</issue>
<fpage>7205</fpage>
<lpage>7212</lpage>
<history>
<date date-type="received"><day>15</day><month>08</month><year>2016</year></date>
<date date-type="accepted"><day>12</day><month>05</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Pan et al.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Atherosclerosis is characterized by localized lesions distributed in the arterial tree due to the shear stress produced by blood flow. Endothelial cells are directly affected by alterations in blood flow. Dysfunction and injury to endothelial cells has been hypothesized to initiate the pathological processes of atherosclerosis. The present study aimed to investigate the mechanism of shear stress-induced endothelial cellular apoptosis. Shear stress was generated using an artificial device to mimic the impact of disturbed blood flow on cultured human aortic endothelial cells (HAECs). Cellular apoptosis was assessed using a terminal deoxynucleotidyl transferase dUTP nick end labeling assay; an ELISA assay was used to detect the produced interleukin (IL)-1&#x03B2;; specific small interfering (si)RNA was used to knockdown the expression of interleukin-1 receptor-associated kinase 2 (IRAK2) in HAECs and the expression levels of 78 kDa glucose-regulated protein, DNA damage-inducible transcript 3 protein (CHOP), IRAK2 and IL-1&#x03B2; were evaluated using western blotting. The results of the present study demonstrated that artificial shear stress induced endoplasmic reticulum (ER) stress, IL-1&#x03B2; production and apoptosis in HAECs in a time-dependent manner. The inhibition of ER stress, and treatment with interleukin-1 receptor antagonist protein and siRNA against IRAK2 attenuated shear stress-induced CHOP signaling-mediated cellular apoptosis. Therefore, overproduction of IL-1&#x03B2; exacerbated shear stress-induced ER stress-mediated apoptosis via the IRAK2/CHOP signaling pathway in endothelial cells.</p>
</abstract>
<kwd-group>
<kwd>endothelial cells</kwd>
<kwd>endoplasmic reticulum stress</kwd>
<kwd>apoptosis</kwd>
<kwd>inflammation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>A number of pathogenic factors, including environmental risk factor exposure, aging, genetic defects and metabolic disorders, are frequently associated with the development of atherosclerosis. As atherosclerotic lesions primarily emerge and develop locally at typical arterial regions, including branched, bifurcated and curvature sites, the local hemodynamics of arteries maybe taken into consideration when investigating the pathogenesis of atherosclerosis (<xref rid="b1-mmr-16-05-7205" ref-type="bibr">1</xref>). Generally, two types of blood flow patterns characterize the local arterial hemodynamics: The steady laminar blood flow (s-flow), and the disturbed blood flow (d-flow) (<xref rid="b2-mmr-16-05-7205" ref-type="bibr">2</xref>). Vascular regions dominated by s-flow are relatively atheroresistant; however, d-flow, comprising transient flow, separated flow and reversal, frequently results in shear stress, which makes the subjected vascular region atherosusceptible (<xref rid="b3-mmr-16-05-7205" ref-type="bibr">3</xref>).</p>
<p>Vascular endothelial cells (ECs) form the inner wall of arterial vessels, and are therefore directly exposed to the blood flow. Under mechanical stimuli, including d-flow, ECs modulate various biological responses, including vasoconstriction maladjustment, local inflammation, oxidative stress and cellular apoptosis (<xref rid="b4-mmr-16-05-7205" ref-type="bibr">4</xref>). Injury to the arterial endothelium serves an important role in the development of inflammation, redox and coagulation, making the vessel atherosusceptible (<xref rid="b5-mmr-16-05-7205" ref-type="bibr">5</xref>). A variety of signal transduction pathways may lead to the apoptosis of ECs. It has previously been demonstrated that the mitochondria-induced, death receptor-induced and endoplasmic reticulum stress-induced pathways are the three primary terminal apoptotic signaling pathways (<xref rid="b6-mmr-16-05-7205" ref-type="bibr">6</xref>&#x2013;<xref rid="b8-mmr-16-05-7205" ref-type="bibr">8</xref>).</p>
<p>The majority of newly-synthesized proteins are folded and matured in the endoplasmic reticulum (ER). When the cell is exposed to stressful conditions, the folding and maturation processes cease and the unfolded protein response is initiated. When the accumulation of unfolded/misfolded proteins exceeds the capacity of the ER to correct the assembly of abnormally-folded proteins, the ER stress response is triggered to provoke multiple pathological alterations (<xref rid="b9-mmr-16-05-7205" ref-type="bibr">9</xref>). As one of the molecular chaperones of ER, 78 kDa glucose-regulated protein (GRP78) binds to stress sensors of the ER (serine/threonine protein kinase/endoribonuclease IRE1, eukaryotic translation initiation factor 2-&#x03B1; kinase 3 and cyclic AMP-dependent transcription factor ATF6-&#x03B1;) to keep the apoptotic signaling inactive under normal physiological conditions. However, under stressful conditions, GRP78 disassociates from the stress signal transducers to trigger the activation of their signaling pathways. Previous studies have demonstrated that ER stress may induce cellular apoptosis through the DNA damage-inducible transcript 3 protein (CHOP) pathway (<xref rid="b10-mmr-16-05-7205" ref-type="bibr">10</xref>). Activated CHOP is able to initiate the translocation of caspase12 from the ER to the plasma in order to trigger the activation of the caspase cascade (<xref rid="b11-mmr-16-05-7205" ref-type="bibr">11</xref>). CHOP is generally considered to be a pro-apoptotic factor (<xref rid="b12-mmr-16-05-7205" ref-type="bibr">12</xref>). A previous study demonstrated that exposure of cultured ECs to d-flow results in an increase in the expression level of GRP78, indicating that d-flow is one of the pathological initiators of ER stress. These previous results formed the basis of the investigation into the involvement of ER stress in the apoptosis of ECs exposed to d-flow (<xref rid="b13-mmr-16-05-7205" ref-type="bibr">13</xref>).</p>
<p>In addition, it has been hypothesized that inflammation may be important in accelerating and exacerbating the formation and rupture of atherosclerotic plaques (<xref rid="b14-mmr-16-05-7205" ref-type="bibr">14</xref>). Inflammatory cytokines, including tumor necrosis factor-&#x03B1; (TNF-&#x03B1;) and interleukins (ILs) are important transducers and amplifiers of these processes (<xref rid="b15-mmr-16-05-7205" ref-type="bibr">15</xref>). It was reported that TNF-&#x03B1; may further recruit and stimulate the expression of other ILs to exacerbate inflammation (<xref rid="b16-mmr-16-05-7205" ref-type="bibr">16</xref>). The IL-1 family is associated with the occurrence and development of numerous inflammatory diseases. A previous study demonstrated that the use of antagonists, including interleukin-1 receptor antagonist protein (IL-1Ra) and interleukin-36 receptor antagonist protein was able to relieve local and systemic inflammation (<xref rid="b17-mmr-16-05-7205" ref-type="bibr">17</xref>). A recent study observed that IL-1&#x03B2; promoted ER stress-induced cellular apoptosis via interleukin-1 receptor associated kinase 2 (IRAK2) (<xref rid="b18-mmr-16-05-7205" ref-type="bibr">18</xref>). In the present study, using an artificial <italic>in vitro</italic> model to mimic d-flow, cultured human aortic endothelial cells (HAECs) were exposed to shear stress. By using an ER stress inhibitor and specific small interfering (si)RNA against IRAK2, the involvement of IRAK2/CHOP signaling in ER stress-mediated shear stress-induced cellular apoptosis was investigated.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Cell culture and treatment</title>
<p>HAECs were purchased from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China) and cultured in Dulbecco&#x0027;s modified Eagle&#x0027;s medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10&#x0025; fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.). L-glutamine (2 mmol/l; Invitrogen; Thermo Fisher Scientific, Inc.) and antibiotics (1&#x0025; penicillin/streptomycin; Invitrogen; Thermo Fisher Scientific, Inc.). Cells were cultured in a cell incubator providing a humidified environment, with 5&#x0025; CO<sub>2</sub> and 95&#x0025; air at 37&#x00B0;C. Equal amounts of cells were divided into 7 groups, namely the control group (Control), 4-phenylbutyrate (4-PBA)-treated group (4-PBA), d-flow-exposed group (d-flow), siRNA-treated group (siRNA), IL-1Ra-treated d-flow-exposed group (IL-1Ra&#x002B;d-flow), 4-PBA-treated d-flow-exposed group (4-PBA&#x002B;d-flow) and siRNA treated d-flow-exposed group (d-flow&#x002B;siRNA). Cell treatments are listed in <xref rid="tI-mmr-16-05-7205" ref-type="table">Table I</xref>.</p>
</sec>
<sec>
<title>Target gene silencing using siRNA</title>
<p>In accordance with a previous study, IRAK2 in HAECs was silenced using siRNA (<xref rid="b18-mmr-16-05-7205" ref-type="bibr">18</xref>). The sequence of the siRNA against IRAK2 was 5&#x2032;-CTTCGCCTCCTACGTGATCAC-3&#x2032;, and was acquired from Shanghai GenePharma Co., Ltd. (Shanghai, China). A scramble sequence, 5&#x2032;-GAACAGACGACGTTGACAA-3&#x2032;, was used as the scramble control. According to the manufacturer&#x0027;s protocol, using HiPerFect siRNA transfection reagent (Qiagen GmbH, Hilden, Germany), the siRNAs were transfected into HAECs at final concentrations of 12.5 mmol/l. Cells were used for subsequent experiments following 24 h culturing.</p>
</sec>
<sec>
<title>Artificial d-flow model</title>
<p>The artificial d-flow model was created using a cone-and-plate chamber according to the description in a previous report (<xref rid="b19-mmr-16-05-7205" ref-type="bibr">19</xref>). This apparatus consists of a cone rotating about its center axis in a tissue culture dish to produce stable laminar flow. The components of the cone-and-late apparatus were produced at the College of Machinery of Xi&#x0027;an Jiaotong University (Xi&#x0027;an, China). The HAECs were exposed to d-flow for 0.5, 1, 2, 3 and 4 h.</p>
</sec>
<sec>
<title>Cellular apoptosis assay</title>
<p>Cellular apoptosis was detected using a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. The <italic>In Situ</italic> Cell Death Detection kit (Roche Diagnostics, Basel, Switzerland) was used to perform the detection. Following fixation with 4&#x0025; paraformaldehyde for 12 h at room temperature (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany), cultured HAECs were permeabilized using 1&#x0025; Triton X-100 (Sigma-Aldrich; Merck KGaA). Cells were subsequently treated with TUNEL staining solution for 1 h at 37&#x00B0;C in accordance with manufacturer&#x0027;s protocol. After washing the slides five times in PBS and mounted with 3&#x0025; hydrogen peroxide in formaldehyde, a fluorescence microscope was used to observe TUNEL positive cells. Five fields of view were selected.</p>
</sec>
<sec>
<title>IL-1&#x03B2; concentration detection</title>
<p>IL-1&#x03B2; concentration in the cell culture supernatants was measured using an ELISA assay, with a Quantkine Rat IL-1&#x03B2; ELISA kit (catalog no. DLB50; R&#x0026;D Systems, Inc., Minneapolis, MN, USA). The measurements were carried out according to the manufacturer&#x0027;s protocol. Standard curves and absorbance values were used to calculate the concentrations.</p>
</sec>
<sec>
<title>Western blotting</title>
<p>Harvested HAECs were washed and lysed in radioimmunoprecipitation assay buffer (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) supplemented with phenylmethylsulfonyl fluoride (0.5 mmol/l; Santa CruzBiotechnology, Inc.), dithiothreitol (1 mmol/l; Beyotime Institute of Biotechnology, Haimen, China) and protease inhibitor (150 mmol/l; Invitrogen; Thermo Fisher Scientific, Inc.). Protein concentrations were determined using the colorimetric Bradford assay (Pierce; Thermo Fisher Scientific, Inc.). A total of 10 &#x00B5;g protein was loaded onto 10&#x0025; gels and subjected to SDS-PAGE, and the loaded proteins were separated by vertical electrophoresis. Proteins were subsequently electronically transferred to polyvinylidene fluoride or nitrocellulose membranes (EMD Millipore, Billerica, MA, USA). Following blocking for 1 h in 5&#x0025; non-fat milk in TBST for 1 h at 25&#x00B0;C, specific antibodies against IL-1&#x03B2; (catalog no. sc-130323; Santa Cruz Biotechnology, Inc.; dilution 1:2,000), GRP78 (catalog no. 3183; 1:2,000; Cell Signaling Technology, Inc., Danvers, MA, USA), IRAK2 (catalog no. ab62419; 1:1,000; Abcam, Cambridge, UK), CHOP (catalog no. ab10444; 1:2,000; Abcam), caspase 12 (catalog no. ab62484; 1:1,000; Abcam) and GAPDH (catalog no. ab8245; 1:5,000; Abcam) were used to incubate the membranes for 12 h at 4&#x00B0;C. Corresponding horseradish peroxidase-conjugated secondary antibodies (catalog no. ab7010, Abcam; catalog no. sc2364 and sc3747; Santa Cruz Biotechnology, Inc.) were used to incubate the membranes for 1 h at room temperature, which were illuminated using SuperSignal West Pico enhanced chemiluminescence reagents (Pierce; Thermo Fisher Scientific, Inc.).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Data acquired in the present study are presented as the mean &#x00B1; standard deviation of three independent experiments. The data were analyzed using SPSS software, version 16.0 (SPSS, Inc., Chicago, IL, USA). Differences between groups were analyzed using one-way analysis of variance followed by Bonferroni&#x0027;s post hoc test. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>d-flow triggers the activation of ER stress, which induces HAEC apoptosis in a time-dependent manner</title>
<p>As presented in <xref rid="f1-mmr-16-05-7205" ref-type="fig">Fig. 1</xref>, following exposure to d-flow, ER stress-mediated apoptotic signaling was observed to be activated in HAECs in a time-dependent manner. The expression levels of the molecular markers of this pathway, GRP78 and CHOP, were observed to be significantly increased in a time-dependent manner. The actual time-dependent d-flow induced apoptosis was observed using a TUNEL assay.</p>
</sec>
<sec>
<title>Exposure to d-flow increases the synthesis and secretion of IL-1&#x03B2; in cultured HAECs, in a time-dependent manner</title>
<p>As demonstrated in <xref rid="f2-mmr-16-05-7205" ref-type="fig">Fig. 2</xref>, the synthesis of IL-1&#x03B2; was significantly increased in d-flow-treated HAECs in a time-dependent manner, which was evidenced by an increased protein expression level in harvested HAECs. Additionally, the secretion of IL-1&#x03B2; in d-flow-treated HAECs was observed to be increased in a time-dependent manner, evidenced by increased protein expression in the supernatant of cultured HAECs.</p>
</sec>
<sec>
<title>4-PBA incubation attenuates d-flow-mediated HAEC death by suppressing ER stress</title>
<p>Treatment with 4-PBA treatment significantly decreased the expression of GRP78 and CHOP, which were considered to be molecular markers of ER stress-mediated apoptotic signaling. Additionally, results from the TUNEL assay and the expression levels of caspase12 demonstrated that the d-flow induced ER stress mediated apoptosis was inhibited by 4-PBA in HAECs (<xref rid="f3-mmr-16-05-7205" ref-type="fig">Fig. 3</xref>).</p>
</sec>
<sec>
<title>IL-1Ra incubation lowers the apoptotic rate of d-flow-exposed HAECs by inhibiting IRAK2/CHOP signaling</title>
<p>The association between IL-1Ra and alterations in d-flow-induced ER stress-mediated signal transduction and actual apoptosis are demonstrated in <xref rid="f4-mmr-16-05-7205" ref-type="fig">Fig. 4</xref>. IL-1Ra did not affect cellular apoptosis (determined by TUNEL assay and caspase12 expression level) in untreated HAECs. However, the d-flow-induced apoptosis was significantly inhibited by IL-1Ra administration. It was additionally observed that in d-flow-treated HAECs, IL-1Ra treatment decreased the expression of IRAK2 and CHOP without affecting the expression levels of GRP78 and IL-1&#x03B2;. The results of the present study indicated that the IL-1Ra inhibited apoptotic signal transduction during ER stress by affecting the signal transduction of IRAK2/CHOP.</p>
</sec>
<sec>
<title>siRNA against IRAK2 attenuates d-flow-mediated HAEC apoptosis by blocking IRAK2/CHOP signaling</title>
<p>In order to further confirm the role of IRAK2/CHOP signaling in mediating d-flow-induced HAEC apoptosis, RNA interference was performed. siRNA against IRAK2 was transfected into HAECs. As presented in <xref rid="f5-mmr-16-05-7205" ref-type="fig">Fig. 5</xref>, IRAK2 siRNA transfection exhibited apparent inhibitory effects on cellular apoptosis (determined by TUNEL assay and caspase12 expression level analysis) induced by d-flow. IRAK2 siRNA transfection markedly inhibited the expression levels of CHOP in d-flow treated HAECs. However, the expression levels of GRP78 and IL-1&#x03B2; were not affected by IRAK2 siRNA transfection.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Atherosclerotic vascular disease-associated mortality represents a large proportion of cerebrovascular and cardiovascular mortalities worldwide. In the arterial tree, distinct lesions may be observed in different regions due to regional differences in shear stress forces produced by blood flow (<xref rid="b20-mmr-16-05-7205" ref-type="bibr">20</xref>). A previous study indicated that exposure to d-flow triggers pathological alterations which render ECs dysfunctional and proatherogenic (<xref rid="b21-mmr-16-05-7205" ref-type="bibr">21</xref>). Apoptosis in the endothelium modulates biological alterations within the vessel wall, including deregulation of vascular wall remodeling, decreased production of vasorelaxant substances and initiation of the coagulation cascade and pro-inflammatory processes (<xref rid="b22-mmr-16-05-7205" ref-type="bibr">22</xref>&#x2013;<xref rid="b24-mmr-16-05-7205" ref-type="bibr">24</xref>). These alterations have been hypothesized to be the mechanisms underlying atherosclerosis. In the present study, cultured HAECs were exposed to d-flow generated by an artificial device. It was observed that d-flow induced the apoptosis of HAECs in a time-dependent manner.</p>
<p>The ER is an important cellular organelle, primarily involved in directing protein folding, modification and maturation. Under certain pathological circumstances, when ER stress is severe and prolonged, signal transductions are activated to trigger multiple biological effects (<xref rid="b25-mmr-16-05-7205" ref-type="bibr">25</xref>). <italic>In vivo</italic> and <italic>in vitro</italic> investigations have demonstrated the association between ER stress and atherosclerosis (<xref rid="b26-mmr-16-05-7205" ref-type="bibr">26</xref>). Administration of an exogenous ER stress activator was observed to promote the formation of atherosclerotic plaques (<xref rid="b27-mmr-16-05-7205" ref-type="bibr">27</xref>). Evidence of ER stress activation has additionally been observed within the human atherosclerotic endothelium (<xref rid="b28-mmr-16-05-7205" ref-type="bibr">28</xref>). In addition, ER stress was demonstrated to induce apoptosis in endothelial cells (<xref rid="b29-mmr-16-05-7205" ref-type="bibr">29</xref>). Therefore, it may be hypothesized that d-flow-induced EC apoptosis is mediated by ER stress. The present study demonstrated that the expression of GRP78, considered to be the chaperone of ER stress, was increased significantly in HAECs following exposure to d-flow. The expression of the pro-apoptotic factor of ER stress, CHOP, was additionally observed to be elevated in d-flow-treated HAECs. The results of the present study indicated that d-flow-induced apoptosis was mediated by ER stress. 4-PBA is one of the specific suppressors of ER stress. In the present study, treatment with 4-PBA inhibited the increased expression levels of GRP78 and CHOP. Therefore, 4-PBA impaired d-flow-induced ER stress-mediated HAEC apoptosis. The results of the present study further supported the hypothesis that d-flow-induced HAEC apoptosis is mediated by ER stress.</p>
<p>It is widely accepted that atherosclerosis is induced and promoted by molecular and cellular pathways of inflammation. Numerous inflammatory cytokines, including TNF-&#x03B1;, tumor growth factor-&#x03B2; and IL-1 provide mechanisms that may be able to alter the arterial biology of the endothelium to favor plaque formation and atherothrombotic events (<xref rid="b30-mmr-16-05-7205" ref-type="bibr">30</xref>). In a previous study, inflammation and ER stress were hypothesized to be associated as they share a number of effectors and regulators (<xref rid="b31-mmr-16-05-7205" ref-type="bibr">31</xref>). A &#x2018;vicious cycle&#x2019; was proposed, since inflammatory and ER stress signals were observed to exacerbate cellular apoptosis via their interactions (<xref rid="b32-mmr-16-05-7205" ref-type="bibr">32</xref>). In the present study, it was demonstrated that, following d-flow exposure, expression level of IL-1&#x03B2; in HAECs and their supernatant increased significantly. ER stress and inflammatory signaling were simultaneously initiated. However, following treatment with the IL-1&#x03B2; receptor antagonist IL-1Ra, cellular apoptosis was attenuated. IL-1Ra treatment decreased the expression level of CHOP in d-flow-treated cells. The results of the present study indicated that IL-1&#x03B2; promoted ER stress-mediated cellular apoptosis via the CHOP signaling pathway.</p>
<p>By binding to its receptor IL-1R, IL-1&#x03B2; activates downstream signaling transduction by forming the IL-1R-AcP complex with an accessory protein (AcP). The C-terminal death domain of this complex couples IRAKs and subsequently activates TNF receptor associated factor-6 to initiate the apoptotic pathway (<xref rid="b33-mmr-16-05-7205" ref-type="bibr">33</xref>,<xref rid="b34-mmr-16-05-7205" ref-type="bibr">34</xref>). The close association between ER stress-mediated apoptosis and IRAK2 was identified by a previous study (<xref rid="b18-mmr-16-05-7205" ref-type="bibr">18</xref>), the results of which demonstrated that the expression of IRAK2 increases in conditions of ER stress. In addition, increased IRAK2 promotes CHOP expression, which transduces the death signal in ER stress-mediated apoptosis. In the present study, RNA interference was used to knockdown the expression of IRAK2. The results of the present study demonstrated that the knockdown of IRAK2 significantly inhibited the d-flow-induced apoptosis of HAECs. It was additionally observed that the knockdown of IRAK2 suppressed the expression of CHOP without an apparent affect on GRP78 and IL-1&#x03B2;. The results of the present study indicated that the secreted IL-1&#x03B2; in d-flow-treated HAECs was involved in exacerbating apoptosis through the IRAK2/CHOP signaling pathway.</p>
<p>In conclusion, by activating ER stress, exposure to d-flow induced HAEC apoptosis via the CHOP signaling pathway. The inflammatory cytokine IL-1&#x03B2; was produced in d-flow-treated HAECs. IL-1&#x03B2; exacerbated d-flow-induced cellular apoptosis. In addition, the apoptotic signal was transduced via the IL-1&#x03B2;/IRAK2/CHOP signaling pathway. This signaling pathway may be considered to be crosstalk between ER stress and inflammation under conditions of disturbed blood flow. The results of the present study may provide a theoretical basis for the identification of potential molecular targets for the treatment of atherosclerosis.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The present study was supported by the project fund of Shaanxi Province Science and Technology Key Projects (grant no. 2016YFJH2-05).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-16-05-7205"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gimbrone</surname><given-names>MA</given-names><suffix>Jr</suffix></name><name><surname>Garc&#x00ED;a-Carde&#x00F1;a</surname><given-names>G</given-names></name></person-group><article-title>Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis</article-title><source>Cardiovasc Pathol</source><volume>22</volume><fpage>9</fpage><lpage>15</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.carpath.2012.06.006</pub-id><pub-id pub-id-type="pmid">22818581</pub-id></element-citation></ref>
<ref id="b2-mmr-16-05-7205"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>KS</given-names></name><name><surname>Le</surname><given-names>NT</given-names></name><name><surname>Cushman</surname><given-names>HJ</given-names></name><name><surname>Giancursio</surname><given-names>CJ</given-names></name><name><surname>Chang</surname><given-names>E</given-names></name><name><surname>Woo</surname><given-names>CH</given-names></name><name><surname>Sullivan</surname><given-names>MA</given-names></name><name><surname>Taunton</surname><given-names>J</given-names></name><name><surname>Yeh</surname><given-names>ET</given-names></name><name><surname>Fujiwara</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>J</given-names></name></person-group><article-title>Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function</article-title><source>J Clin Invest</source><volume>125</volume><fpage>1299</fpage><lpage>1310</lpage><year>2015</year><pub-id pub-id-type="doi">10.1172/JCI76453</pub-id><pub-id pub-id-type="pmid">25689261</pub-id><pub-id pub-id-type="pmcid">4362265</pub-id></element-citation></ref>
<ref id="b3-mmr-16-05-7205"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Q</given-names></name></person-group><article-title>Disturbed flow-enhanced endothelial turnover in atherosclerosis</article-title><source>Trends Cardiovasc Med</source><volume>19</volume><fpage>191</fpage><lpage>195</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.tcm.2009.12.002</pub-id><pub-id pub-id-type="pmid">20211434</pub-id></element-citation></ref>
<ref id="b4-mmr-16-05-7205"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>KS</given-names></name><name><surname>Fujiwara</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>J</given-names></name></person-group><article-title>Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction</article-title><source>Circ J</source><volume>75</volume><fpage>2722</fpage><lpage>2730</lpage><year>2011</year><pub-id pub-id-type="doi">10.1253/circj.CJ-11-1124</pub-id><pub-id pub-id-type="pmid">22076424</pub-id><pub-id pub-id-type="pmcid">3620204</pub-id></element-citation></ref>
<ref id="b5-mmr-16-05-7205"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Heiden</surname><given-names>K</given-names></name><name><surname>Hierck</surname><given-names>BP</given-names></name><name><surname>Krams</surname><given-names>R</given-names></name><name><surname>de Crom</surname><given-names>R</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Baiker</surname><given-names>M</given-names></name><name><surname>Pourquie</surname><given-names>MJ</given-names></name><name><surname>Alkemade</surname><given-names>FE</given-names></name><name><surname>DeRuiter</surname><given-names>MC</given-names></name><name><surname>Gittenberger-de Groot</surname><given-names>AC</given-names></name><name><surname>Poelmann</surname><given-names>RE</given-names></name></person-group><article-title>Endothelial primary cilia in areas of disturbed flow are at the base of atherosclerosis</article-title><source>Atherosclerosis</source><volume>196</volume><fpage>542</fpage><lpage>550</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2007.05.030</pub-id><pub-id pub-id-type="pmid">17631294</pub-id></element-citation></ref>
<ref id="b6-mmr-16-05-7205"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hida</surname><given-names>A</given-names></name><name><surname>Kawakami</surname><given-names>A</given-names></name><name><surname>Miyashita</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>Nakashima</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>F</given-names></name><name><surname>Izumi</surname><given-names>Y</given-names></name><name><surname>Tamai</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Ida</surname><given-names>H</given-names></name><etal/></person-group><article-title>Nitric oxide acts on the mitochondria and protects human endothelial cells from apoptosis</article-title><source>J Lab Clin Med</source><volume>144</volume><fpage>148</fpage><lpage>155</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.lab.2004.04.009</pub-id><pub-id pub-id-type="pmid">15454884</pub-id></element-citation></ref>
<ref id="b7-mmr-16-05-7205"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>ZL</given-names></name><name><surname>Zhang</surname><given-names>JP</given-names></name><name><surname>Guo</surname><given-names>XC</given-names></name></person-group><article-title>Endoplasmic reticulum stress and vascular endothelial cell apoptosis</article-title><source>Zhongguo Yi Xue Ke Xue Yuan Xue Bao</source><volume>36</volume><fpage>102</fpage><lpage>107</lpage><year>2014</year><comment>(In Chinese)</comment><pub-id pub-id-type="pmid">24581138</pub-id></element-citation></ref>
<ref id="b8-mmr-16-05-7205"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skurk</surname><given-names>C</given-names></name><name><surname>Walsh</surname><given-names>K</given-names></name></person-group><article-title>Death receptor induced apoptosis: A new mechanism of homocysteine-mediated endothelial cell cytotoxicity</article-title><source>Hypertension</source><volume>43</volume><fpage>1168</fpage><lpage>1170</lpage><year>2004</year><pub-id pub-id-type="doi">10.1161/01.HYP.0000127811.48554.12</pub-id><pub-id pub-id-type="pmid">15096473</pub-id></element-citation></ref>
<ref id="b9-mmr-16-05-7205"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pluquet</surname><given-names>O</given-names></name><name><surname>Pourtier</surname><given-names>A</given-names></name><name><surname>Abbadie</surname><given-names>C</given-names></name></person-group><article-title>The unfolded protein response and cellular senescence. A review in the theme: Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease</article-title><source>Am J Physiol Cell Physiol</source><volume>308</volume><fpage>C415</fpage><lpage>C425</lpage><year>2015</year><pub-id pub-id-type="doi">10.1152/ajpcell.00334.2014</pub-id><pub-id pub-id-type="pmid">25540175</pub-id></element-citation></ref>
<ref id="b10-mmr-16-05-7205"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Xia</surname><given-names>Z</given-names></name><name><surname>Hou</surname><given-names>LN</given-names></name><name><surname>Fang</surname><given-names>C</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>HZ</given-names></name></person-group><article-title>Desipramine induces apoptosis in rat glioma cells via endoplasmic reticulum stress-dependent CHOP pathway</article-title><source>J Neurooncol</source><volume>101</volume><fpage>41</fpage><lpage>48</lpage><year>2011</year><pub-id pub-id-type="doi">10.1007/s11060-010-0237-2</pub-id><pub-id pub-id-type="pmid">20549303</pub-id></element-citation></ref>
<ref id="b11-mmr-16-05-7205"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakshmanan</surname><given-names>AP</given-names></name><name><surname>Thandavarayan</surname><given-names>RA</given-names></name><name><surname>Palaniyandi</surname><given-names>SS</given-names></name><name><surname>Sari</surname><given-names>FR</given-names></name><name><surname>Meilei</surname><given-names>H</given-names></name><name><surname>Giridharan</surname><given-names>VV</given-names></name><name><surname>Soetikno</surname><given-names>V</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Kodama</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name></person-group><article-title>Modulation of AT-1R/CHOP-JNK-Caspase12 pathway by olmesartan treatment attenuates ER stress-induced renal apoptosis in streptozotocin-induced diabetic mice</article-title><source>Eur J Pharm Sci</source><volume>44</volume><fpage>627</fpage><lpage>634</lpage><year>2011</year><pub-id pub-id-type="pmid">22033153</pub-id></element-citation></ref>
<ref id="b12-mmr-16-05-7205"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Morishima</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Yankner</surname><given-names>BA</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><article-title>Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta</article-title><source>Nature</source><volume>403</volume><fpage>98</fpage><lpage>103</lpage><year>2000</year><pub-id pub-id-type="doi">10.1038/47513</pub-id><pub-id pub-id-type="pmid">10638761</pub-id></element-citation></ref>
<ref id="b13-mmr-16-05-7205"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>PF</given-names></name><name><surname>Civelek</surname><given-names>M</given-names></name></person-group><article-title>Endoplasmic reticulum stress, redox, and a proinflammatory environment in athero-susceptible endothelium in vivo at sites of complex hemodynamic shear stress</article-title><source>Antioxid Redox Signal</source><volume>15</volume><fpage>1427</fpage><lpage>1432</lpage><year>2011</year><pub-id pub-id-type="doi">10.1089/ars.2010.3741</pub-id><pub-id pub-id-type="pmid">21126204</pub-id><pub-id pub-id-type="pmcid">3144426</pub-id></element-citation></ref>
<ref id="b14-mmr-16-05-7205"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x00E4;ck</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>C</given-names></name><name><surname>Lutgens</surname><given-names>E</given-names></name></person-group><article-title>Regulation of atherosclerotic plaque inflammation</article-title><source>J Intern Med</source><volume>278</volume><fpage>462</fpage><lpage>482</lpage><year>2015</year><pub-id pub-id-type="doi">10.1111/joim.12367</pub-id><pub-id pub-id-type="pmid">25823439</pub-id></element-citation></ref>
<ref id="b15-mmr-16-05-7205"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewberry</surname><given-names>R</given-names></name><name><surname>Holden</surname><given-names>H</given-names></name><name><surname>Crossman</surname><given-names>D</given-names></name><name><surname>Francis</surname><given-names>S</given-names></name></person-group><article-title>Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>20</volume><fpage>2394</fpage><lpage>2400</lpage><year>2000</year><pub-id pub-id-type="doi">10.1161/01.ATV.20.11.2394</pub-id><pub-id pub-id-type="pmid">11073843</pub-id></element-citation></ref>
<ref id="b16-mmr-16-05-7205"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balato</surname><given-names>A</given-names></name><name><surname>Di Caprio</surname><given-names>R</given-names></name><name><surname>Canta</surname><given-names>L</given-names></name><name><surname>Mattii</surname><given-names>M</given-names></name><name><surname>Lembo</surname><given-names>S</given-names></name><name><surname>Raimondo</surname><given-names>A</given-names></name><name><surname>Schiattarella</surname><given-names>M</given-names></name><name><surname>Balato</surname><given-names>N</given-names></name><name><surname>Ayala</surname><given-names>F</given-names></name></person-group><article-title>IL-33 is regulated by TNF-&#x03B1; in normal and psoriatic skin</article-title><source>Arch Dermatol Res</source><volume>306</volume><fpage>299</fpage><lpage>304</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s00403-014-1447-9</pub-id><pub-id pub-id-type="pmid">24522896</pub-id></element-citation></ref>
<ref id="b17-mmr-16-05-7205"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattii</surname><given-names>M</given-names></name><name><surname>Ayala</surname><given-names>F</given-names></name><name><surname>Balato</surname><given-names>N</given-names></name><name><surname>Filotico</surname><given-names>R</given-names></name><name><surname>Lembo</surname><given-names>S</given-names></name><name><surname>Schiattarella</surname><given-names>M</given-names></name><name><surname>Patruno</surname><given-names>C</given-names></name><name><surname>Marone</surname><given-names>G</given-names></name><name><surname>Balato</surname><given-names>A</given-names></name></person-group><article-title>The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: The role of IL-1 family members</article-title><source>Exp Dermatol</source><volume>22</volume><fpage>813</fpage><lpage>819</lpage><year>2013</year><pub-id pub-id-type="doi">10.1111/exd.12272</pub-id><pub-id pub-id-type="pmid">24164463</pub-id></element-citation></ref>
<ref id="b18-mmr-16-05-7205"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>N</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>Circulating interleukin-1&#x03B2; promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2</article-title><source>Cardiovasc Diabetol</source><volume>14</volume><fpage>125</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12933-015-0288-y</pub-id><pub-id pub-id-type="pmid">26394923</pub-id><pub-id pub-id-type="pmcid">4580368</pub-id></element-citation></ref>
<ref id="b19-mmr-16-05-7205"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhart-King</surname><given-names>CA</given-names></name><name><surname>Fujiwara</surname><given-names>K</given-names></name><name><surname>Berk</surname><given-names>BC</given-names></name></person-group><article-title>Physiologic stress-mediated signaling in the endothelium</article-title><source>Methods Enzymol</source><volume>443</volume><fpage>25</fpage><lpage>44</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/S0076-6879(08)02002-8</pub-id><pub-id pub-id-type="pmid">18772009</pub-id></element-citation></ref>
<ref id="b20-mmr-16-05-7205"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>KS</given-names></name><name><surname>Fujiwara</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>J</given-names></name></person-group><article-title>Shear stress and atherosclerosis</article-title><source>Mol Cells</source><volume>37</volume><fpage>435</fpage><lpage>440</lpage><year>2014</year><pub-id pub-id-type="doi">10.14348/molcells.2014.0078</pub-id><pub-id pub-id-type="pmid">24781409</pub-id><pub-id pub-id-type="pmcid">4086336</pub-id></element-citation></ref>
<ref id="b21-mmr-16-05-7205"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>PF</given-names></name><name><surname>Civelek</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Guerraty</surname><given-names>MA</given-names></name><name><surname>Passerini</surname><given-names>AG</given-names></name></person-group><article-title>Endothelial heterogeneity associated with regional athero-susceptibility and adaptation to disturbed blood flow in vivo</article-title><source>Semin Thromb Hemost</source><volume>36</volume><fpage>265</fpage><lpage>275</lpage><year>2010</year><pub-id pub-id-type="doi">10.1055/s-0030-1253449</pub-id><pub-id pub-id-type="pmid">20533180</pub-id></element-citation></ref>
<ref id="b22-mmr-16-05-7205"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Tian</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Jing</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>SS</given-names></name><name><surname>Chen</surname><given-names>YD</given-names></name></person-group><article-title>Atherosclerosis-associated endothelial cell apoptosis by MiR-429-mediated down regulation of Bcl-2</article-title><source>Cell Physiol Biochem</source><volume>37</volume><fpage>1421</fpage><lpage>1430</lpage><year>2015</year><pub-id pub-id-type="doi">10.1159/000438511</pub-id><pub-id pub-id-type="pmid">26489013</pub-id></element-citation></ref>
<ref id="b23-mmr-16-05-7205"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>L</given-names></name><name><surname>Zampetaki</surname><given-names>A</given-names></name><name><surname>Margariti</surname><given-names>A</given-names></name><name><surname>Pepe</surname><given-names>AE</given-names></name><name><surname>Alam</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>D</given-names></name><name><surname>Xiao</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Jin</surname><given-names>ZG</given-names></name><name><surname>Cockerill</surname><given-names>G</given-names></name><etal/></person-group><article-title>Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow</article-title><source>Proc Natl Acad Sci USA</source><volume>106</volume><fpage>8326</fpage><lpage>8331</lpage><conf-date>2009</conf-date><pub-id pub-id-type="doi">10.1073/pnas.0903197106</pub-id><pub-id pub-id-type="pmid">19416856</pub-id><pub-id pub-id-type="pmcid">2676169</pub-id></element-citation></ref>
<ref id="b24-mmr-16-05-7205"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choy</surname><given-names>JC</given-names></name><name><surname>Granville</surname><given-names>DJ</given-names></name><name><surname>Hunt</surname><given-names>DW</given-names></name><name><surname>McManus</surname><given-names>BM</given-names></name></person-group><article-title>Endothelial cell apoptosis: Biochemical characteristics and potential implications for atherosclerosis</article-title><source>J Mol Cell Cardiol</source><volume>33</volume><fpage>1673</fpage><lpage>1690</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/jmcc.2001.1419</pub-id><pub-id pub-id-type="pmid">11549346</pub-id></element-citation></ref>
<ref id="b25-mmr-16-05-7205"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>SS</given-names></name><name><surname>Kaufman</surname><given-names>RJ</given-names></name></person-group><article-title>Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease</article-title><source>Antioxid Redox Signal</source><volume>21</volume><fpage>396</fpage><lpage>413</lpage><year>2014</year><pub-id pub-id-type="doi">10.1089/ars.2014.5851</pub-id><pub-id pub-id-type="pmid">24702237</pub-id><pub-id pub-id-type="pmcid">4076992</pub-id></element-citation></ref>
<ref id="b26-mmr-16-05-7205"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group><article-title>Endoplasmic reticulum stress and atherosclerosis</article-title><source>Nat Med</source><volume>16</volume><fpage>396</fpage><lpage>399</lpage><year>2010</year><pub-id pub-id-type="doi">10.1038/nm0410-396</pub-id><pub-id pub-id-type="pmid">20376052</pub-id><pub-id pub-id-type="pmcid">2897068</pub-id></element-citation></ref>
<ref id="b27-mmr-16-05-7205"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabas</surname><given-names>I</given-names></name></person-group><article-title>The role of endoplasmic reticulum stress in the progression of atherosclerosis</article-title><source>Circ Res</source><volume>107</volume><fpage>839</fpage><lpage>850</lpage><year>2010</year><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.224766</pub-id><pub-id pub-id-type="pmid">20884885</pub-id><pub-id pub-id-type="pmcid">2951143</pub-id></element-citation></ref>
<ref id="b28-mmr-16-05-7205"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanova</surname><given-names>EA</given-names></name><name><surname>Orekhov</surname><given-names>AN</given-names></name></person-group><article-title>The role of endoplasmic reticulum stress and unfolded protein response in atherosclerosis</article-title><source>Int J Mol Sci</source><volume>17</volume><fpage>pii:E193</fpage><year>2016</year><pub-id pub-id-type="doi">10.3390/ijms17020193</pub-id></element-citation></ref>
<ref id="b29-mmr-16-05-7205"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>JP</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>YL</given-names></name><name><surname>Chen</surname><given-names>MX</given-names></name></person-group><article-title>Endoplasmic reticulum stress-mediated aldosterone-induced apoptosis in vascular endothelial cells</article-title><source>J Huazhong Univ Sci Technolog Med Sci</source><volume>34</volume><fpage>821</fpage><lpage>824</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s11596-014-1359-0</pub-id><pub-id pub-id-type="pmid">25480576</pub-id></element-citation></ref>
<ref id="b30-mmr-16-05-7205"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krams</surname><given-names>R</given-names></name><name><surname>Segers</surname><given-names>D</given-names></name><name><surname>Gourabi</surname><given-names>B Mousavi</given-names></name><name><surname>Maat</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>van Pelt</surname><given-names>C</given-names></name><name><surname>van Damme</surname><given-names>LC</given-names></name><name><surname>de Feyter</surname><given-names>P</given-names></name><name><surname>Van Der Steen</surname><given-names>T</given-names></name><name><surname>de Korte</surname><given-names>CL</given-names></name><name><surname>Serruys</surname><given-names>PW</given-names></name></person-group><article-title>Inflammation and atherosclerosis: Mechanisms underlying vulnerable plaque</article-title><source>J Interv Cardiol</source><volume>16</volume><fpage>107</fpage><lpage>113</lpage><year>2003</year><pub-id pub-id-type="doi">10.1046/j.1540-8183.2003.08021.x</pub-id><pub-id pub-id-type="pmid">12768913</pub-id></element-citation></ref>
<ref id="b31-mmr-16-05-7205"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>T</given-names></name></person-group><article-title>Astragaloside-IV alleviates Heat-induced inflammation by inhibiting endoplasmic reticulum stress and autophagy</article-title><source>Cell Physiol Biochem</source><volume>42</volume><fpage>824</fpage><lpage>837</lpage><year>2017</year><pub-id pub-id-type="doi">10.1159/000478626</pub-id><pub-id pub-id-type="pmid">28641278</pub-id></element-citation></ref>
<ref id="b32-mmr-16-05-7205"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benosman</surname><given-names>S</given-names></name><name><surname>Ravanan</surname><given-names>P</given-names></name><name><surname>Correa</surname><given-names>RG</given-names></name><name><surname>Hou</surname><given-names>YC</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Gulen</surname><given-names>MF</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Cuddy</surname><given-names>M</given-names></name><name><surname>Matsuzawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Interleukin-1 receptor-associated kinase-2 (IRAK2) is a critical mediator of endoplasmic reticulum (ER) stress signaling</article-title><source>PLoS One</source><volume>8</volume><fpage>e64256</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0064256</pub-id><pub-id pub-id-type="pmid">23724040</pub-id><pub-id pub-id-type="pmcid">3665826</pub-id></element-citation></ref>
<ref id="b33-mmr-16-05-7205"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cenni</surname><given-names>V</given-names></name><name><surname>Sirri</surname><given-names>A</given-names></name><name><surname>De Pol</surname><given-names>A</given-names></name><name><surname>Maraldi</surname><given-names>NM</given-names></name><name><surname>Marmiroli</surname><given-names>S</given-names></name></person-group><article-title>Interleukin-1-receptor-associated kinase 2 (IRAK2)-mediated interleukin-1-dependent nuclear factor kappaB transactivation in Saos2 cells requires the Akt/protein kinase B kinase</article-title><source>Biochem J</source><volume>376</volume><fpage>303</fpage><lpage>311</lpage><year>2003</year><pub-id pub-id-type="doi">10.1042/bj20030028</pub-id><pub-id pub-id-type="pmid">12906710</pub-id><pub-id pub-id-type="pmcid">1223745</pub-id></element-citation></ref>
<ref id="b34-mmr-16-05-7205"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><article-title>TRAF6 regulates proliferation, apoptosis, and invasion of osteosarcoma cell</article-title><source>Mol Cell Biochem</source><volume>371</volume><fpage>177</fpage><lpage>186</lpage><year>2012</year><pub-id pub-id-type="doi">10.1007/s11010-012-1434-4</pub-id><pub-id pub-id-type="pmid">22886393</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-16-05-7205" position="float">
<label>Figure 1.</label>
<caption><p>Analysis of apoptosis in HAECs exposed to d-flow. (A) The upper panel demonstrates the captured images from the terminal deoxynucleotidyl transferase dUTP nick end labeling assay of HAECs treated with d-flow for 0.5, 1, 2, 3 and 4 h. The graph on the lower panel indicates the detected apoptotic percentage of HAECs. Magnification, &#x00D7;200. (B) The upper panel exhibits the immunoblotting analysis of GRP78, CHOP and GAPDH in HAECs treated with d-flow for 0.5, 1, 2, 3 and 4 h. The graph on the lower panel presents the relative expression levels of GRP78 (white columns) and CHOP (black columns), with GAPDH as the internal reference. &#x002A;P&#x003C;0.05 vs. 0.5 h; <sup>#</sup>P&#x003C;0.05 vs. 1 h; <sup>&#x0026;</sup>P&#x003C;0.05 vs. 2 h; <sup>&#x0024;</sup>P&#x003C;0.05 vs. 3 h. HAECs, human aortic endothelial cells; d-flow, disturbed blood flow; GRP78, 78 kDa glucose-regulated protein; CHOP, DNA damage-inducible transcript 3 protein; d-flow, disturbed blood flow.</p></caption>
<graphic xlink:href="MMR-16-05-7205-g00.tif"/>
</fig>
<fig id="f2-mmr-16-05-7205" position="float">
<label>Figure 2.</label>
<caption><p>Analysis of IL-1&#x03B2; expression in HAECs exposed to d-flow. (A) The upper panel exhibits the representative image of the western blotting of IL-1&#x03B2; and GAPDH in HAECs treated with d-flow for 0.5, 1, 2, 3 and 4 h. The graph on the lower panel indicates the relative expression of IL-1&#x03B2; in HAECs, with GAPDH as the internal reference. (B) Results of the ELISA assay of IL-1&#x03B2;. The graph exhibits the detected IL-1&#x03B2; concentrations in the supernatant of cultured HAECs treated with d-flow for 0.5, 1, 2, 3 and 4 h. &#x002A;P&#x003C;0.05 vs. 0.5 h; <sup>#</sup>P&#x003C;0.05 vs. 1 h; <sup>&#x0026;</sup>P&#x003C;0.05 vs. 2 h; <sup>&#x0024;</sup>P&#x003C;0.05 vs. 3 h. HAECs, human aortic endothelial cells; IL-1&#x03B2;, interleukin-1&#x03B2;; d-flow, disturbed blood flow.</p></caption>
<graphic xlink:href="MMR-16-05-7205-g01.tif"/>
</fig>
<fig id="f3-mmr-16-05-7205" position="float">
<label>Figure 3.</label>
<caption><p>Analysis of the effects of treatment with 4-PBA in HAECs exposed to d-flow. (A) Results of western blotting of GRP78, CHOP, caspase 12 and GAPDH in HAECs treated with 4-PBA and/or d-flow. The relative expression of GRP78 (white columns) and CHOP (black columns) in HAECs treated with 4-PBA and/or d-flow was normalized to GAPDH. (B) The left panel exhibits the captured images from the terminal deoxynucleotidyl transferase dUTP nick end labeling assay of HAECs treated with 4-PBA and/or d-flow. The detected apoptotic percentages of HAECs treated with 4-PBA and/or d-flow were quantified. Magnification, &#x00D7;200. &#x002A;P&#x003C;0.05 vs. Ctrl; <sup>#</sup>P&#x003C;0.05 vs. Ctrl&#x002B;4-PBA; <sup>&#x0026;</sup>P&#x003C;0.05 vs. d-flow. HAECs, human aortic endothelial cells; d-flow, disturbed blood flow; GRP78, 78 kDa glucose-regulated protein; CHOP, DNA damage-inducible transcript 3 protein; 4-PBA, 4-phenylbutyric acid; Ctrl, control.</p></caption>
<graphic xlink:href="MMR-16-05-7205-g02.tif"/>
</fig>
<fig id="f4-mmr-16-05-7205" position="float">
<label>Figure 4.</label>
<caption><p>Analysis of the effects of treatment with IL-1Ra in HAECs exposed to d-flow. (A) Results of the western blotting of GRP78, IL-1&#x03B2;, IRAK2, CHOP, caspase 12 and GAPDH in HAECs treated with IL-1Ra and/or d-flow. The relative expressions of GRP78 (white columns), IL-1&#x03B2; (light gray columns), IRAK2 (dark gray columns) and CHOP (black columns) were normalized to GAPDH. (B) Images were captured of the terminal deoxynucleotidyl transferase dUTP nick end labeling assay of HAECs treated with IL-1Ra and/or d-flow. The detected apoptotic percentages of HAECs treated by IL-1Ra and/or d-flow were quantified. Magnification, &#x00D7;200. &#x002A;P&#x003C;0.05 vs. Ctrl; <sup>#</sup>P&#x003C;0.05 vs. Ctrl&#x002B;IL-1Ra; <sup>&#x0026;</sup>P&#x003C;0.05 vs. d-flow. IL-1Ra, interleukin-1 receptor antagonist protein; GRP78, 78 kDa glucose-regulated protein; CHOP, DNA damage-inducible transcript 3 protein; d-flow, disturbed blood flow; HAECs, human aortic endothelial cells; Ctrl, control; IRAK2, interleukin-1 receptor associated kinase 2; IL-1&#x03B2;, interleukin-1&#x03B2;.</p></caption>
<graphic xlink:href="MMR-16-05-7205-g03.tif"/>
</fig>
<fig id="f5-mmr-16-05-7205" position="float">
<label>Figure 5.</label>
<caption><p>Analysis of the effects of treatment with IRAK2 siRNA in HAECs exposed to d-flow. (A) Results of the immunoblotting of GRP78, IL-1&#x03B2;, IRAK2, CHOP, caspase 12 and GAPDH in HAECs treated with IRAK2 siRNA and/or d-flow. The relative expression of GRP78 (white columns), IL-1&#x03B2; (light gray columns), IRAK2 (dark gray columns) and CHOP (black columns) was normalized to GAPDH. (B) Images were captured of the terminal deoxynucleotidyl transferase dUTP nick end labeling assay of HAECs treated with IRAK2 siRNA and/or d-flow. The detected apoptotic percentages of HAECs treated with IRAK2 siRNA and/or d-flow were quantified. Magnification, &#x00D7;200. &#x002A;P&#x003C;0.05 vs. Ctrl; <sup>#</sup>P&#x003C;0.05 vs. Ctrl&#x002B;IRAKdn; <sup>&#x0026;</sup>P&#x003C;0.05 vs. d-flow. GRP78, 78 kDa glucose-regulated protein; CHOP, DNA damage-inducible transcript 3 protein; d-flow, disturbed blood flow; HAECs, human aortic endothelial cells; Ctrl, control; IRAK2, interleukin-1 receptor associated kinase 2; IL-1&#x03B2;, interleukin-1&#x03B2;; IRAKdn, IRAK downregulated; siRNA, small interfering RNA.</p></caption>
<graphic xlink:href="MMR-16-05-7205-g04.tif"/>
</fig>
<table-wrap id="tI-mmr-16-05-7205" position="float">
<label>Table I.</label>
<caption><p>Cell grouping and treatments.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Groups</th>
<th align="center" valign="bottom">Treatment reagent</th>
<th align="center" valign="bottom">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Control</td>
<td align="left" valign="top">Medium</td>
<td align="left" valign="top">Treated with control medium</td>
</tr>
<tr>
<td align="left" valign="top">4-PBA</td>
<td align="left" valign="top">4-PBA</td>
<td align="left" valign="top">Treated with 4-PBA at concentration of 0.6 mmol/l</td>
</tr>
<tr>
<td align="left" valign="top">siRNA</td>
<td align="left" valign="top">siRNA</td>
<td align="left" valign="top">Specific siRNA against IRAK2</td>
</tr>
<tr>
<td align="left" valign="top">d-flow</td>
<td align="left" valign="top">d-flow</td>
<td align="left" valign="top">Artificial d-flow model</td>
</tr>
<tr>
<td align="left" valign="top">d-flow&#x002B;IL-1Ra</td>
<td align="left" valign="top">IL-1Ra and d-flow</td>
<td align="left" valign="top">Treated with IL-1Ra at concentration of 200 ng/ml when exposed to d-flow</td>
</tr>
<tr>
<td align="left" valign="top">d-flow&#x002B;4PBA</td>
<td align="left" valign="top">4-PBA and d-flow</td>
<td align="left" valign="top">Treated with 4-PBA when exposed to d-flow</td>
</tr>
<tr>
<td align="left" valign="top">d-flow&#x002B;siRNA</td>
<td align="left" valign="top">siRNA and d-flow</td>
<td align="left" valign="top">Pretreated with siRNA against IRAK2 and subse quently exposed to d-flow</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-mmr-16-05-7205"><p>4-PBA, 4-phenylbutyric acid; d-flow, disturbed blood flow; siRNA, small interfering RNA; IL-1Ra, interleukin-1 receptor antagonist protein.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>